Epstein File EFTA02295528: Immunity Grant, Targeted and Treat (DS11)

Epstein Index›Documents›EFTA02295528

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA02295528: Immunity Grant, Targeted and Treat (DS11)

General DocumentDate unavailableEFTA022955281 keyword hits

0

views

0

shares

0

reactions

0

persons

7

keywords

9

excerpts

This document appears to reference a cell propagation and concentration incubator used for medical or scientific purposes, specifically related to patient cell activation and infusion preparation. The document mentions GMP (Good Manufacturing Practice) oncolytic reagents and seems to be a technical description of a laboratory equipment or process.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

incubator immunity targeted treat Silicon Valley penetration vulnerable

📋 Key Excerpts9

PersonKeyword

Excerpt 1

Cell Propagation/Concentration **incubator** GMP Oncolytic Reagents agent Introduced introduced Patient Cell Activation **Incubator** Infusion Preparation DÄCART

Excerpt 2

Conferring long term **immunity** to tumor cells, post-therapy Incorporating simplified, cost-effective, and scalable immunotherapy production at the point

Excerpt 3

The technology platform produces oncolytic agents that are highly tumoricidal, and after therapy there is sustained **immunity** against the cancer type that